Journal of Medicinal Chemistry · 2005 · 203 citations · 26 references
We report here the synthesis and the strong and unexpected antiproliferative effect of the organometallic diphenolic compound 1,1-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene (4) on both hormone-dependent (MCF7) and -independent (MDA-MB231) breast cancer cells (IC(50) = 0.7 and 0.6 microM). Surprisingly, 6 [1,2-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene], the regioisomer of 4, shows only a modest effect on these cell lines. This pertinent organometallic modification seems to trigger an intracellular oxidation of the structurally favorable compound 4, leading to the generation of a potent cytotoxic compound.
26
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Jennifer L. Bowers, Valentyn V. Tyulmenkov, Sarah Jernigan et al. · Endocrinology · 2000 · 525 citations · Full text
Mitochondrial localization of estrogen receptor β
Shao-Hua Yang, Ran Liu, Evelyn J. Perez et al. · Proceedings of the National Academy of Sciences · 2004 · 496 citations · Full text
Siden Top, Anne Vessières, Guy Leclercq et al. · Chemistry - A European Journal · 2003 · 400 citations
Bioorganic Chemistry, Organic Chemistry, Pharmacotherapy +22